← Back to Search

Discharge Teaching Tools for Hospital Discharge Equity (TIDE Trial)

N/A
Recruiting
Led By Kirsten Austad, MD MPH
Research Sponsored by Boston Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

TIDE Trial Summary

This trial will test a package of linguistically appropriate discharge teaching tools to improve patient understanding & key outcomes for those with Limited English Proficiency.

Who is the study for?
This trial is for patients at Boston Medical Center who prefer Spanish, Haitian Creole, Cape Verdean Creole, or Vietnamese and are being discharged home. Participants must be adults admitted to specific units and have family/visitors present at discharge. Excluded are those with cognitive issues, certain infections or on suicide precautions.Check my eligibility
What is being tested?
The study tests a set of tools designed to help patients with limited English understand their discharge instructions better. These include a medication calendar in multiple languages, pictographics for return precautions, and an audio summary review.See study design
What are the potential side effects?
Since this trial involves educational tools rather than medications or medical procedures, traditional side effects aren't expected. However, there may be varying levels of satisfaction or effectiveness perceived by the participants.

TIDE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient understanding of discharge instructions
Patient understanding of primary diagnosis of hospitalization
Secondary outcome measures
Hospital re-utilization
Implementation effectiveness
Medication adherence
+2 more

TIDE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Discharge equity toolsExperimental Treatment1 Intervention
Participants randomized into this arn will receive the toolkit of linguistically appropriate discharge teaching aids at hospital discharge.
Group II: Standard of hospital discharge careActive Control1 Intervention
Participants randomized into this arm will receive the standard of care at hospital discharge.

Find a Location

Who is running the clinical trial?

Boston Medical CenterLead Sponsor
384 Previous Clinical Trials
871,434 Total Patients Enrolled
Kirsten Austad, MD MPHPrincipal InvestigatorBoston Medical Center, Family Medicine

Media Library

Discharge equity tools Clinical Trial Eligibility Overview. Trial Name: NCT05988229 — N/A
Hospital Discharge Research Study Groups: Standard of hospital discharge care, Discharge equity tools
Hospital Discharge Clinical Trial 2023: Discharge equity tools Highlights & Side Effects. Trial Name: NCT05988229 — N/A
Discharge equity tools 2023 Treatment Timeline for Medical Study. Trial Name: NCT05988229 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there currently an opportunity for patients to participate in this experiment?

"According to clinicaltrials.gov, this study is not currently seeking participants and has not been updated since August 10th 2023. However, there are other trials ongoing that may be suitable for those looking to enroll in a medical trial at this time."

Answered by AI

What aims are researchers looking to accomplish with this trial?

"The primary measure of this trial's success is the patient's comprehension of their initial diagnosis. Secondary metrics such as medication adherence, re-utilization rates for hospital visits or ED trips within 30 days post discharge and completion of follow-up care will be calculated using the MMAS-8 questionnaire which scores each item on a 5 point Likert scale."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Tools to Improve Discharge Equity (TIDE) Pilot RCT
2023. "Tools to Improve Discharge Equity (TIDE) Pilot RCT". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05988229.
~125 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top